Literature DB >> 2189549

The colony stimulating factors. Discovery, development, and clinical applications.

D Metcalf1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2189549     DOI: 10.1002/1097-0142(19900515)65:10<2185::aid-cncr2820651005>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  27 in total

Review 1.  New perspectives in lung cancer.5. New drugs in lung cancer.

Authors:  D C Talbot; I E Smith
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

Review 2.  The discovery, development and clinical applications of granulocyte colony-stimulating factor.

Authors:  D C Dale
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

3.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product.

Authors:  R E Hall; S Agarwal; D P Kestler; J A Cobb; K M Goldstein; N S Chang
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 5.  Overview of the lenograstim pharmacoeconomics programme.

Authors:  G Oster; J Menzin; D Richard; V Cour-Chabernaud
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

6.  LIM domain only 4 protein promotes granulocyte colony-stimulating factor-induced signaling in neurons.

Authors:  Mariana Gomez-Smith; Zhaohong Qin; Xun Zhou; Sarah C Schock; Hsiao-Huei Chen
Journal:  Cell Mol Life Sci       Date:  2009-12-10       Impact factor: 9.261

Review 7.  The colony stimulating factors.

Authors:  M Hansson; T Söderström
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

8.  Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation. A prospective randomized study.

Authors:  A Torres Gómez; M A Jimenez; M A Alvarez; A Rodriguez; C Martin; M J Garcia; R Flores; J Sanchez; M J de la Torre; C Herrera
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

9.  Protection of taurine and granulocyte colony-stimulating factor against excitotoxicity induced by glutamate in primary cortical neurons.

Authors:  Chunliu Pan; Amit Gupta; Howard Prentice; Jang-Yen Wu
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 10.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.